|
|
||||||||||
|
J Am Coll Cardiol, 1999; 33:598-604 © 1999 by the American College of Cardiology Foundation |


a Clinical Trials Group, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA
Office of Biostatistics Research, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA
# Cardiovascular Division, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA
Manuscript received February 18, 1998; revised manuscript received October 22, 1998, accepted November 16, 1998.
Reprint requests and correspondence: Michael J. Domanski, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892
Domanskm{at}gwgate.nhlbi.nih.gov
OBJECTIVES
Estimate the effect of angiotensin converting enzyme (ACE) inhibitors on the risk of sudden cardiac death (SCD) following myocardial infarction (MI).
BACKGROUND
Trials in post-MI patients have shown that ACE inhibitor therapy reduces mortality. However, the effect on SCD as a mechanism has not been clarified.
METHODS
Trials of ACE inhibitor therapy following MI reported between January, 1978 and August, 1997 were identified. Studies were included if they met the following criteria: 1) randomized comparison of ACE inhibitor to placebo within 14 days of MI; 2) study duration/blinded follow-up of
6 weeks; 3) the number of deaths and modes of death were reported or could be obtained from the investigators.
RESULTS
We identified 374 candidate articles, of which 15 met the inclusion criteria. The 15 trials included 15,104 patients, 2,356 of whom died. Most (87%) fatalities were cardiovascular and 900 were SCDs. A significant reduction in SCD risk or a trend towards this was observed in all of the larger (N > 500) trials. Overall, ACE inhibitor therapy resulted in significant reductions in risk of death (random effects odds ratio [OR] = 0.83; 95% confidence interval [CI] 0.710.97), cardiovascular death (OR = 0.82; 95% CI 0.690.97) and SCD (OR = 0.80; 95% CI 0.700.92).
CONCLUSIONS
This analysis is consistent with prior reports showing that ACE inhibitors decrease the risk of death following a recent MI by reducing cardiovascular mortality. Moreover, this analysis suggests that a reduction in SCD risk with ACE inhibitors is an important component of this survival benefit.
| ||||||||||||||
This article has been cited by other articles:
![]() |
R. Due-Andersen, T. Hoi-Hansen, C. E. Larroude, N. V. Olsen, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson Cardiac repolarization during hypoglycaemia in type 1 diabetes: impact of basal renin-angiotensin system activity Europace, July 1, 2008; 10(7): 860 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Due-Andersen, T. Hoi-Hansen, N. V. Olsen, C. E. Larroude, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: impact of renin-angiotensin system activity Europace, February 1, 2008; 10(2): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Myles, C. E. Jackson, I. Tsorlalis, M. C. Petrie, J. J. V. McMurray, and S. M. Cobbe Is Microvolt T-Wave Alternans the Answer to Risk Stratification in Heart Failure? Circulation, December 18, 2007; 116(25): 2984 - 2991. [Full Text] [PDF] |
||||
![]() |
V. S. Kasi, H. D. Xiao, L. L. Shang, S. Iravanian, J. Langberg, E. A. Witham, Z. Jiao, C. J. Gallego, K. E. Bernstein, and S. C. Dudley Jr. Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H182 - H192. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kloner and D. S. Cannom Uncertainty on the Use of Aldosterone Antagonists for Primary Therapy for Sudden Cardiac Death in the Setting of Implanted Devices Circulation, June 12, 2007; 115(23): 2983 - 2989. [Full Text] [PDF] |
||||
![]() |
P. H. Pun, R. W. Lehrich, S. R. Smith, and J. P. Middleton Predictors of Survival after Cardiac Arrest in Outpatient Hemodialysis Clinics Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 491 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Rosen, D. M. Cutler, D. M. Norton, H. M. Hu, and S. Vijan The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002 Health Aff., January 1, 2007; 26(1): 111 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sanders, J. Harris, J. Cooper, P. Gohlke, S. E Humphries, H. Montgomery, and D. R Woods Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 231 - 235. [Abstract] [PDF] |
||||
![]() |
P. Kirchhof, G. Breithardt, and L. Eckardt Primary prevention of sudden cardiac death. Heart, December 1, 2006; 92(12): 1873 - 1878. [Full Text] [PDF] |
||||
![]() |
I Gemmell, R F Heller, P McElduff, K Payne, G Butler, R Edwards, M Roland, and P Durrington Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease J. Epidemiol. Community Health, December 1, 2005; 59(12): 1041 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pitt, the EPHESUS Investigators, F. Zijlstra, I. C.C. van der Horst, A. Khera, B. D. Levine, A. G. Jacobs, S. D. Solomon, R. M. Califf, M. A. Pfeffer, et al. Sudden Death in Patients with Myocardial Infarction N. Engl. J. Med., September 22, 2005; 353(12): 1294 - 1297. [Full Text] [PDF] |
||||
![]() |
N Danchin The changing face of acute myocardial infarction Heart, June 1, 2005; 91(6): 705 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raviele, M. G. Bongiorni, M. Brignole, R. Cappato, A. Capucci, F. Gaita, M. Gulizia, S. Mangiameli, A. S. Montenero, R. F. E. Pedretti, et al. Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment: The BEta-blocker STrategy plus ICD trial Europace, January 1, 2005; 7(4): 327 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Solomon, D. Wang, P. Finn, H. Skali, L. Zornoff, J. J.V. McMurray, K. Swedberg, S. Yusuf, C. B. Granger, E. L. Michelson, et al. Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, October 12, 2004; 110(15): 2180 - 2183. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Teo, L. B. Mitchell, J. Pogue, J. Bosch, G. Dagenais, S. Yusuf, and on behalf of the HOPE Investigators Effect of Ramipril in Reducing Sudden Deaths and Nonfatal Cardiac Arrests in High-Risk Individuals Without Heart Failure or Left Ventricular Dysfunction Circulation, September 14, 2004; 110(11): 1413 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Josephson and H. J.J. Wellens Implantable Defibrillators and Sudden Cardiac Death Circulation, June 8, 2004; 109(22): 2685 - 2691. [Full Text] [PDF] |
||||
![]() |
M. St John Sutton, D. Lee, J. L. Rouleau, S. Goldman, T. Plappert, E. Braunwald, and M. A. Pfeffer Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction Circulation, May 27, 2003; 107(20): 2577 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Kennedy and R. S. Rosenson Physicians' interpretation of "class effects": A need for thoughtful re-evaluation J. Am. Coll. Cardiol., July 3, 2002; 40(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gandjour, F. Kleinschmit, K.W. Lauterbach, and INTERCARE Iternational Investigators European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001) Eur. Heart J., June 1, 2002; 23(11): 858 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Allot, C de Chillou, and N Sadoul Ventricular instability and sudden death in patients with heart failure: lessons from clinical trials Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D31 - D42. [Abstract] [PDF] |
||||
![]() |
S. Schneeweiss, S. B. Soumerai, R. J. Glynn, M. Maclure, C. Dormuth, and A. M. Walker Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization Can. Med. Assoc. J., March 1, 2002; 166(6): 737 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Lorgeril, P. Salen, P. Defaye, P. Mabo, and F. Paillard Dietary prevention of sudden cardiac death Eur. Heart J., February 2, 2002; 23(4): 277 - 285. [Full Text] [PDF] |
||||
![]() |
S. G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, J. A. Camm, R. Cappato, S. M. Cobbe, C. Di Mario, et al. TASK FORCE ON SUDDEN CARDIAC DEATH, EUROPEAN SOCIETY OF CARDIOLOGY: Summary of Recommendations Europace, January 1, 2002; 4(1): 3 - 18. [Abstract] [PDF] |
||||
![]() |
A H Gershlick The acute management of myocardial infarction Br. Med. Bull., October 1, 2001; 59(1): 89 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
![]() |
M. E. Khalil, A. W. Basher, E. J. Brown Jr, and I. A. Alhaddad A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1757 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Mazeika Aborted sudden cardiac death: a clinical perspective Postgrad. Med. J., June 1, 2001; 77(908): 363 - 370. [Abstract] [Full Text] |
||||
![]() |
D. Babuty and M. J Lab Mechanoelectric contributions to sudden cardiac death Cardiovasc Res, May 1, 2001; 50(2): 270 - 279. [Full Text] [PDF] |
||||
![]() |
D.R. Woods, D. Brull, and H. Montgomery Increased QT dispersion with the D-allele of the ACE polymorphism Eur. Heart J., April 2, 2001; 22(8): 618 - 621. [PDF] |
||||
![]() |
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme Eur. Heart J., April 1, 2001; 22(7): 554 - 572. [Abstract] [PDF] |
||||
![]() |
J. Galcera-Tomas, F. J. Castillo-Soria, M. Villegas-Garcia, R. Florenciano-Sanchez, J. G. Sanchez-Villanueva, J. A. N. de la Rosa, A. Martinez-Caballero, J. A. Valenti-Aldeguer, P. Jara-Perez, M. Parraga-Ramirez, et al. Effects of Early Use of Atenolol or Captopril on Infarct Size and Ventricular Volume : A Double-Blind Comparison in Patients With Anterior Acute Myocardial Infarction Circulation, February 13, 2001; 103(6): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. O'Keefe, M. Wetzel, R. R. Moe, K. Brosnahan, and C. J. Lavie Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease? J. Am. Coll. Cardiol., January 1, 2001; 37(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E WIEGERS and M. S. J. SUTTON When should ACE inhibitors or warfarin be discontinued after myocardial infarction? Heart, October 1, 2000; 84(4): 361 - 362. [Full Text] |
||||
![]() |
S. Saksena Implantable defibrillators in the third millennium: increasingly relegated to a standby role? J. Am. Coll. Cardiol., September 1, 2000; 36(3): 828 - 831. [Full Text] [PDF] |
||||
![]() |
E.E. van der Wall and J.J. Bax Different imaging approaches in the assessment of left ventricular dysfunction: all things equal? Eur. Heart J., August 2, 2000; 21(16): 1295 - 1297. [PDF] |
||||
![]() |
S. Greenberg, G. Chemin, I. Shapira, J. George, Y. Wollman, S. Laniado, and G. Keren Captopril and L-Arginine Have a Synergistic Cardioprotective Effect in Ischemic-Reperfusion Injury in the Isolated Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 281 - 290. [Abstract] [PDF] |
||||
![]() |
ACE Inhibitors Reduce Sudden Cardiac Death Journal Watch Cardiology, May 7, 1999; 1999(507): 5 - 5. [Full Text] |
||||
![]() |
ACE Inhibitors Reduce Sudden Cardiac Death After MI Journal Watch Dermatology, May 1, 1999; 1999(501): 18 - 18. [Full Text] |
||||
![]() |
ACE Inhibitors Reduce Sudden Cardiac Death After MI Journal Watch (General), March 16, 1999; 1999(316): 2 - 2. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |